GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 9.88

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.37M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

N/A

USD 76.31B
VTR Ventas Inc

N/A

USD 26.47B
DOC Healthpeak Properties Inc

N/A

USD 15.80B
CTRE CareTrust REIT Inc.

N/A

USD 4.74B
AHR American Healthcare REIT, Inc.

N/A

USD 3.99B
NHI National Health Investors Inc

N/A

USD 3.65B
LTC LTC Properties Inc

N/A

USD 1.60B
UHT Universal Health Realty Income..

N/A

USD 0.63B
CHCT Community Healthcare Trust Inc

N/A

USD 0.47B
GMRE-PA Global Medical REIT Inc

N/A

USD 0.41B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 5.13 % 0.35 %

N/A

USD 0.25B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.99% 14% F 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.99% 14% F 20% F
Trailing 12 Months  
Capital Gain 10.14% 29% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.14% 29% F 42% F
Trailing 5 Years  
Capital Gain -13.33% 46% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.33% 46% F 35% F
Average Annual (5 Year Horizon)  
Capital Gain -3.26% N/A N/A 22% F
Dividend Return 3.48% N/A N/A 42% F
Total Return 6.74% N/A N/A 88% B+
Risk Return Profile  
Volatility (Standard Deviation) 25.05% N/A N/A 41% F
Risk Adjusted Return 13.89% N/A N/A 34% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:

There is nothing we particularly dislike